IRIS
RICEVUTO, ENRICO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.484
EU - Europa 5.636
AS - Asia 5.162
SA - Sud America 587
Continente sconosciuto - Info sul continente non disponibili 252
AF - Africa 74
OC - Oceania 11
Totale 22.206
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.277
SG - Singapore 2.147
CN - Cina 1.140
IT - Italia 1.103
IE - Irlanda 1.081
RU - Federazione Russa 926
TR - Turchia 696
SE - Svezia 613
DE - Germania 530
BR - Brasile 484
HK - Hong Kong 432
VN - Vietnam 397
GB - Regno Unito 352
UA - Ucraina 340
FR - Francia 272
FI - Finlandia 205
CA - Canada 112
IN - India 78
BD - Bangladesh 73
CZ - Repubblica Ceca 42
JP - Giappone 42
AR - Argentina 34
PL - Polonia 31
MX - Messico 30
BE - Belgio 26
NL - Olanda 24
IQ - Iraq 23
ES - Italia 19
ZA - Sudafrica 19
CO - Colombia 16
MA - Marocco 16
ID - Indonesia 15
EC - Ecuador 14
CL - Cile 13
AT - Austria 12
KR - Corea 12
SA - Arabia Saudita 11
CR - Costa Rica 10
JM - Giamaica 10
MY - Malesia 10
PK - Pakistan 10
RO - Romania 10
UZ - Uzbekistan 10
AE - Emirati Arabi Uniti 9
AU - Australia 9
HN - Honduras 9
PH - Filippine 9
LT - Lituania 8
BG - Bulgaria 7
DZ - Algeria 7
KE - Kenya 7
PY - Paraguay 7
TH - Thailandia 7
VE - Venezuela 7
DM - Dominica 6
EU - Europa 6
PE - Perù 6
PT - Portogallo 6
TN - Tunisia 6
EE - Estonia 5
JO - Giordania 5
NP - Nepal 5
PR - Porto Rico 5
SV - El Salvador 5
DO - Repubblica Dominicana 4
GT - Guatemala 4
PA - Panama 4
AZ - Azerbaigian 3
BO - Bolivia 3
CG - Congo 3
HR - Croazia 3
LU - Lussemburgo 3
MK - Macedonia 3
PS - Palestinian Territory 3
RS - Serbia 3
SY - Repubblica araba siriana 3
TW - Taiwan 3
AO - Angola 2
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BN - Brunei Darussalam 2
BS - Bahamas 2
BY - Bielorussia 2
DK - Danimarca 2
ET - Etiopia 2
IL - Israele 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LB - Libano 2
LY - Libia 2
MD - Moldavia 2
SC - Seychelles 2
TJ - Tagikistan 2
TL - Timor Orientale 2
UY - Uruguay 2
AG - Antigua e Barbuda 1
BH - Bahrain 1
BW - Botswana 1
CI - Costa d'Avorio 1
EG - Egitto 1
Totale 21.941
Salva come PNG Salva come JPEG
Città #
Jacksonville 1.309
Chandler 1.216
Singapore 1.211
Dublin 1.081
San Jose 1.011
Dallas 834
Ashburn 742
Council Bluffs 533
Santa Clara 432
Hong Kong 425
Boardman 410
Izmir 327
Nanjing 236
Milan 199
The Dalles 198
Wilmington 194
San Mateo 191
New York 183
Lawrence 168
Princeton 168
Beijing 166
Ann Arbor 164
Moscow 158
Lauterbourg 114
Ho Chi Minh City 113
Hanoi 107
Los Angeles 97
Nanchang 87
Rome 85
Woodbridge 75
Seattle 68
São Paulo 65
Munich 64
Bremen 61
Shenyang 56
Tianjin 55
Des Moines 49
Helsinki 48
Verona 45
Hebei 44
L'aquila 43
Brno 40
Tokyo 38
Kunming 37
Naples 37
Columbus 36
Hefei 35
Miano 33
Changsha 31
Phoenix 31
Brooklyn 30
Frankfurt am Main 30
Jiaxing 29
Warsaw 28
Sant'egidio Alla Vibrata 27
Toronto 27
Mountain View 26
Orem 26
Brussels 25
North Bergen 25
London 24
Norwalk 24
Montreal 23
Shanghai 23
Dong Ket 22
Hangzhou 22
Jinan 22
Philadelphia 22
San Francisco 22
Chicago 21
Denver 21
Buffalo 19
Dearborn 19
Guangzhou 19
Zhengzhou 19
Atlanta 18
Chennai 18
L’Aquila 18
Florence 17
Pune 17
Auburn Hills 16
Pescara 16
Las Vegas 15
Turin 15
Miami 14
Boston 13
Da Nang 13
Falkenstein 13
Amsterdam 12
Falls Church 12
Lanzhou 12
Monza 12
Ningbo 12
Changchun 11
Haiphong 11
Johannesburg 11
Rio de Janeiro 11
Turku 11
Brasília 10
Brescia 10
Totale 14.083
Salva come PNG Salva come JPEG
Nome #
Pyrroloquinoline Quinone (PQQ) Attenuates Hydrogen Peroxide-Induced Injury Through the Enhancement of Mitochondrial Function in Human Trabecular Meshwork Cells 463
The supportive care task force at the University of L'Aquila: 2-years experience 226
The prevalent KRAS exon 2 c.35 G > A mutation in metastatic colorectal cancer patients: a biomarker of worse prognosis and potential benefit of bevacizumab-containing intensive regimens? 206
KRAS and Two Rare PI3KCA Mutations Coexisting in a Metastatic Colorectal Cancer Patient With Aggressive and Resistant Disease. 198
Tyrosine kinase inhibitor CEP-701 blocks the NTRK1/NGF receptor and limits the invasive capability of prostate cancer cells in vitro 191
Close correlation between MEK/ERK and Aurora-B signaling pathways in sustaining tumorigenic potential and radioresistance of gynecological cancer cell lines 186
Neoadjuvant chemotherapy in breast cancer: a dose-dense schedule in real life and putative role of PIK3CA mutations. 185
Real-life multidisciplinary treatment for unresectable colorectal cancer liver metastases including hepatic artery infusion with chemo-filtration and liquid biopsy precision oncotherapy: observational cohort study 182
Prognostic significance of clinicopathological factors in early breast cancer: 20 years of follow-up in a single-center analysis. 177
Antiproliferative and pro-apoptotic effects of 5-azacytidine in prostate carcinoma cells in vitro involve the recovering of PTEN-mediated Akt activity control and androgen sensitivity 175
P16 hypermethylation contributes to the characterization of gene inactivation profiles in primary gastric cancer 174
Bone targeted therapy for preventing skeletal-related events in metastatic breast cancer 174
Dose-finding study of oxaliplatin associated to capecitabine based preoperative chemoradiotherapy in locally advanced rectal cancer 167
Circulating tumour cell gene expression and chemosensitivity analyses: predictive accuracy for response to multidisciplinary treatment of patients with unresectable refractory recurrent rectal cancer or unresectable refractory colorectal cancer liver metastases 166
New schedule of bevacizumab/paclitaxel as first-line therapy for metastatic HER2-negative breast cancer in a real-life setting 165
Multidisciplinary Treatment, Including Locoregional Chemotherapy, for Merkel-Polyomavirus-Positive Merkel Cell Carcinomas: Perspectives for Patients Exhibiting Oncogenic Alternative Δ exon 6–7 TrkAIII Splicing of Neurotrophin Receptor Tropomyosin-Related Kinase A 164
KRAS, NRAS and BRAF mutations detected by next generation sequencing, and differential clinical outcome in metastatic colorectal cancer (MCRC) patients treated with first line FIr-B/FOx adding bevacizumab (BEV) to triplet chemotherapy. 162
p16 (INK4a, MTS-1) gene polymorphism and methylation status in human pituitary tumors 160
Novel BRCA1 and BRCA2 germline mutations and assessment of mutation spectrum and prevalence in Italian breast and/or ovarian cancer families 159
Multidisciplinary palliation for unresectable recurrent rectal cancer: Hypoxic pelvic perfusion with mitomycin C and oxaliplatin in patients progressing after systemic chemotherapy and radiotherapy, a retrospective cohort study 158
Oncology together for L'Aquila: early resumption of integrated oncological activities after the earthquake 156
Hypoxic pelvic perfusion with cisplatin and mitomycin C in multidisciplinary palliative treatment of patients with unresectable recurrent rectal cancer: A retrospective study 156
Epigenetic modulation of PTEN expression during antiandrogenic therapies in human prostate cancer 156
Effects of Chemotherapy in Patients with Concomitant Aortic Aneurysm and Malignant Disease 155
Differential prognosis of metastatic colorectal cancer patients post-progression to first-line triplet chemotherapy plus bevacizumab, Fir-B/FOx, according to seconde-line treatment and KRAS genotype 154
CXCR4 pharmacogical inhibition reduces bone and soft tissue metastatic burden by affecting tumor growth and tumorigenic potential in prostate cancer preclinical models 154
A gene expression signature from bone metastases as predictor of clinical outcome in breast cancer patients 153
Pain evaluation and management: a survey of Italian radiotherapists 151
New mutations and protein variants of NBSI are identified in cancer cell lines 150
two simulteneous and very uncommom pi3kca mutations in a liver metastasis from colorectal cancer patient with aggressive and resistant disease 150
Trifluoroibuprofen inhibits α-Methylacyl Coenzyme A Racemase (AMACR/P504S), Reduces Cancer Cell Proliferation and Inhibits in Vivo Tumor Growth in Aggressive Prostate Cancer Models. 148
Dose-dense nonpegylated liposomal doxorubicin and docetaxel combination in breast cancer: Dose-finding study 148
Precision oncotherapy based on liquid biopsies in multidisciplinary treatment of unresectable recurrent rectal cancer: a retrospective cohort study 147
Mutazioni della p53 in campioni selezionati di adenocarcinoma del colon dell’Italia Centrale 146
A phase II study of dose-dense epirubicin plus cyclophosphamide followed by docetaxel plus capecitabine and pegfilgrastim support as preoperative therapy for patients with stage II, IIIA breast cancer 146
Dual PI3K/mTOR inhibitor, XL765 (SAR245409), shows superior effects to sole PI3K [XL147 (SAR245408)] or mTOR [rapamycin] inhibition in prostate cancer cell models 146
Recurrent Metastatic Pulmonary Synovial Sarcoma during Pregnancy: A Case Report and Literature Review 145
Bioclinical parameters driving decision-making of subsequent lines of treatment in metastatic castration-resistant prostate cancer 144
Worse prognosis of KRAS c.35 G > A mutant metastatic colorectal cancer (MCRC) patients treated with intensive triplet chemotherapy plus bevacizumab (FIr-B/FOx). 143
An association of epirubicin, etoposide and cisplatin in gastric cancer: a phase II study 141
Poker association of weekly alternating 5-fluorouracil, irinotecan,bevacizumab and oxaliplatin (FIrB/FOx) in first line treatment of metastatic colorectal cancer: a phase II study 140
Assessment and treatment of symptoms among italian medical oncologists 140
Uncoupling of the epidermal growth factor receptor from downstream signal transduction molecules guides the acquired resistance to gefitinib in prostate cancer cells 140
Gabapentin in the treatment of severe sweating experienced by advanced cancer patients 139
Apoptosis induced by oxaliplatin in human colon cancer HCT15 cell line 138
Axitinib after Sunitinib in metastatic renal cancer: Preliminary results from Italian "Real-World" SAX Study 138
Symptoms in advanced cancer: The influence of sex, age, Karnofsky Performance Status and PaP score. 137
Meccanismo d’azione e farmacologia di nuovi composti organometallici nel trattamento del carcinoma del colon-retto. 137
Cardiovascular toxicity following sunitinib therapy in metastatic renal cell carcinoma: a multicenter analysis 137
Oxaliplatin (l-OHP) association with paclitaxel (PTX) or docetaxel (DTX) in NSCLC cell lines: Schedule-dependent activity based on p53/microtubule associated protein 4 (MAP4) interaction 136
Prognostic relevance of PIK3CA mutations in breast cancer patients treated with primary dose-dense epirubicin/cyclophosphamide -> dose-dense docetaxel 135
Safety and efficacy of nivolumab for metastatic renal cell carcinoma: real-world results from an expanded access programme 135
Prognostic relevance of KRAS genotype in metastatic colorectal cancer patients unfit for FIr-B/FOx intensive regimen 135
A KRAS and dual concomitant PI3KCA mutations in a metastatic colorectal cancer patient with aggressive and resistant disease 133
Increased expression of a set of genes enriched in oxygen binding function discloses a predisposition of breast cancer bone metastases to generate metastasis spread in multiple organs 133
Toxicity Syndromes, Patient-Related Clinical Indicator of Toxicity Burden Induced by Intensive Triplet Chemotherapy-Based Regimens in Gastrointestinal Cancers With Metastatic Disease 133
Recommendations for the implementation of BRCA testing in ovarian cancer patients and their relatives 133
Prognostic relevance of KRAS genotype and the prevalent C.35 G > a mutation in metastatic colorectal cancer (MCRC) patients fitting for intensive FIr-B/FOx triplet chemotherapy plus bevacizumab 132
Hiccup in patients with advanced cancer successfully treated with gabapentin: report of three cases 132
Novel P53 mutations detected by FAMA in colorectal cancers 131
Clinical parameters to guide decision-making in elderly metastatic colorectal CANCER patients treated with intensive cytotoxic and anti-angiogenic therapy 131
Poorly differentiated neuroendocrine rectal carcinoma with uncommon immune-histochemical features and clinical presentation with a subcutaneous metastasis, treated with first line intensive triplet chemotherapy plus bevacizumab FIr-B/FOx regimen: An experience of multidisciplinary management in clinical practice 131
Prevalence of BRCA1 and BRCA2 genomic rearrangements in a cohort of consecutive Italian breast and/or ovarian cancer. families 130
In vivo bone metastases, osteoclastogenic ability, and phenotypic characterization of human cancer cells 130
Multidisciplinary management of hepatocellular carcinoma in clinical practice 128
Efficacy of treatment with tetracyclines to prevent acneiform eruption secondary to cetuximab therapy 127
Triplet schedule of weekly 5-fluorouracil and alternating irinotecan or oxaliplatin in advanced colorectal cancer: a dose-finding and phase II study 127
A six-gene signature predicting breast cancer lung metastasis 126
Recommendations for the implementation of BRCA testing in the care and treatment pathways of ovarian cancer patients 126
Short-term weekly neoadjuvant chemotherapy in the treatment of locally advanced cervical cancer 126
Relevance of Pharmacogenomics and Multidisciplinary Management in a Young-Elderly Patient WithKRASMutant Colorectal Cancer Treated With First-Line Aflibercept-Containing Chemotherapy 125
Azacitidine improves antitumor effects of docetaxel and cisplatin in aggressive prostate cancer models 124
Effects of EGFR tyrosine kinase inhibitor erlotinib in prostate cancer cells in vitro 123
NEW MUTATIONS AND PROTEIC VARIANTS OF NBS1 ARE IDENTIFIED IN CANCER CELL LINES 123
Effectiveness of liver metastasectomies in patients with metastatic colorectal cancer treated with FIr-B/FOx triplet chemotherapy plus bevacizumab. 123
Oxaliplatin:preclinical in vitro studies 123
Tailoring the dosing schedule of nab-paclitaxel in metastatic breast cancer according to patient and disease characteristics: Recommendations from a panel of experts 123
Real life triplet FIr/FOx chemotherapy in first-line metastatic pancreatic ductal adenocarcinoma patients: Recommended schedule for expected activity and safety and phase II study 123
Familiarity and heredity of tumors in function of an early surgical therapeutic approach 122
Plasma proteomic profiling in hereditary breast cancer reveals a BRCA1-specific signature: Diagnostic and functional implications 122
In vitro and in vivo effects of bicalutamide on the expression of TrkA and P75 neurotrophin receptors in prostate carcinoma 121
Medical emergencies in oncology: hypercalcemia. II. Diagnosisand therapy 121
Valutazioni seriate del peptide natriuretico cerebrale sono predittive di cardiotossicità da antracicline in pazienti sottoposti a chemioterapia non ad alte dosi 121
Awareness of disease severity in Italian breast cancer patients submitted to mastectomy or conservative surgery 121
Choice of chemotherapy schedules in elderly patients (> 75 years) with metastatic colorectal cancer (mcrc) according to comorbidity 121
Can analysis of the molecular status of the p53 gene contribute to improving the therapeutic strategy for breast carcinoma? 121
Functional categories of TP53 mutation in colorectal cancer: results of an International Collaborative Study 120
Timed flat infusion of 5-fluorouracil increases the tolerability of 5-fluorouracil/docetaxel regimen in metastatic breast cancer: a dose-finding study 118
Effectiveness and safety of intensive triplet chemotherapy plus bevecizumab, FIr-B/FOx, in young-elderly metastatic colorectal cancer 118
Role of immunoscintigraphy in clinical assessment of gastrointestinal tumors 118
Different expressivity of BRCA1 and BRCA2: analysis of 179 Italian pedigrees with identified mutation 118
Intensive first-line FIr-C/FOx-C association of triplet chemotherapy plus cetuximab in RAS wild-type metastatic colorectal cancer patients: preliminary phase II data and prediction of individual limiting toxicity syndromes by pharmacogenomic biomarkers. 118
Intraperitoneal chemotherapy [LA CHEMIOTERAPIA INTRAPERITONEALE] 117
Significato prognostico e predittivo delle alterazioni genetiche nel carcinoma gastrico 117
Triplet Chemotherapy in Patients With Metastatic Colorectal Cancer: Toward the Best Way to Safely Administer a Highly Active Regimen in Clinical Practice 117
ABERRANT HYPERMETHYLATION OF THE P16 GENE IN SPORADIC GASTRIC CANCER 115
Evaluation of widely used models for predicting BRCA1 and BRCA2 mutations 115
Phenotypic characterization of human prostatic stromal cells in primary cultures derived from human tissue samples. 115
Role of estrogen receptor alpha in aggressiveness and osteoclastogenic potential of human breast carcinoma cells. 115
Downmodulation of dimethyl transferase activity enhances tumor necrosis factor-related apoptosis-inducing ligand-inducedapoptosis in prostate cancer cells 114
Totale 14.415
Salva come PNG Salva come JPEG
Categoria #
all - tutte 89.871
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 89.871
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022679 0 0 0 73 32 18 12 55 66 21 76 326
2022/20233.321 233 205 61 358 346 378 5 212 1.375 13 78 57
2023/2024717 116 44 33 103 50 178 16 63 0 28 27 59
2024/20253.197 97 73 308 134 439 268 469 286 678 83 199 163
2025/20266.313 310 635 553 714 553 496 1.148 214 494 656 405 135
2026/20272.140 146 236 503 1.255 0 0 0 0 0 0 0 0
Totale 22.206